SGC STIMULATOR, BAY41 8543, FOR THE TREATMENT OF HEART FAILURE WITH REDUCED EJECTION FRACTION AND CARDIORENAL SYNDROME.

被引：0
|
作者：
Gawrys, Olga [1 ]
Skaroupkova, Petra [1 ]
Huskova, Zuzana [1 ]
Honetschlagerova, Zuzana [1 ]
Vanourkova, Zdenka [1 ]
Kikerlova, Sona [1 ]
Melenovsky, Vojtech [2 ]
Cervenka, Ludek [1 ]
机构：
[1] Inst Clin & Expt Med, Ctr Med Expt, Prague, Czech Republic
[2] Inst Clin & Expt Med, Dept Cardiol, Prague, Czech Republic
来源：
JOURNAL OF HYPERTENSION | 2023年 / 41卷
关键词：
D O I：
暂无
中图分类号：
R6 [外科学];
学科分类号：
1002 ; 100210 ;
摘要：
PS-B03-2
引用
收藏
页码：E356 / E356
页数：1
相关论文
共 50 条
  • [1] sGC stimulator (BAY 41-8543) for the treatment of heart failure with reduced ejection fraction (HFrEF) and cardio-renal syndrome
    Gawrys, Olga
    Huskova, Zuzana
    Skaroupkova, Petra
    Honetschlagerova, Zuzana
    Vanourkova, Zdenka
    Kikerlova, Sona
    Melenovsky, Vojtech
    Cervenka, Ludek
    JOURNAL OF TRANSLATIONAL MEDICINE, 2023, 21
  • [2] sGC stimulator (BAY 41-8543) for the treatment of heart failure with reduced ejection fraction (HFrEF) and cardio-renal syndrome
    Gawrys, Olga
    Huskova, Zuzana
    Skaroupkova, Petra
    Honetschlagerova, Zuzana
    Vanourkova, Zdenka
    Kikerlova, Sona
    Melenovsky, Vojtech
    Cervenka, Ludek
    JOURNAL OF TRANSLATIONAL MEDICINE, 2023, 21 (SUPPL 1)
  • [3] The sGC stimulator BAY 41-8543 in a rat model of hypertension-induced heart failure
    N Haase
    N Wilck
    L Marko
    A Balogh
    A Heuser
    D Brockschnieder
    A Kretschmer
    J P Stasch
    N Müller
    R Dechend
    BMC Pharmacology and Toxicology, 16 (Suppl 1)
  • [4] Cardiorenal Syndrome Caused by Heart Failure with Preserved Ejection Fraction
    Lazzeri, Chiara
    Valente, Serafina
    Tarquini, Roberto
    Gensini, Gian Franco
    INTERNATIONAL JOURNAL OF NEPHROLOGY, 2011, 2011
  • [5] The Role of sGC Stimulators and Activators in Heart Failure With Reduced Ejection Fraction
    Cordwin, David J.
    Berei, Theodore J.
    Pogue, Kristen T.
    JOURNAL OF CARDIOVASCULAR PHARMACOLOGY AND THERAPEUTICS, 2021, 26 (06) : 593 - 600
  • [6] Development of vericiguat: The first soluble guanylate cyclase (sGC) stimulator launched for heart failure with reduced ejection fraction (HFrEF)
    Xia, Juan
    Hui, Nan
    Tian, Lei
    Liang, Chengyuan
    Zhang, Jie
    Liu, Jifang
    Wang, Jun
    Ren, Xiaodong
    Xie, Xiaolin
    Wang, Kun
    BIOMEDICINE & PHARMACOTHERAPY, 2022, 149
  • [7] Oral sGC Stimulator Vericiguat in Patients With Worsening Chronic Heart Failure and Reduced Ejection Fraction - The SOluble guanylate Cyclase stimulatoR in heArT failurE patientS With REDUCED EF (SOCRATES-REDUCED) Study
    Gheorghiade, Mihai
    Maggioni, Aldo P.
    Lam, Carolyn
    Samano, Eliana
    Kraigher-Krainer, Elisabeth
    Filippatos, Gerasimos
    Butler, Javed
    Greene, Stephen J.
    Mueller, Katharina
    Roessig, Lothar
    Ponikowski, Piotr
    Shah, Sanjiv
    Solomon, Scott D.
    Pieske, Burkert
    CIRCULATION, 2015, 132 (23) : 2268 - 2269
  • [8] The Treatment of Heart Failure with Reduced Ejection Fraction
    Berliner, Dominik
    Haenselmann, Anja
    Bauersachs, Johann
    DEUTSCHES ARZTEBLATT INTERNATIONAL, 2020, 117 (21): : 376 - +
  • [9] Treatment of heart failure with reduced ejection fraction
    Kim, In-Cheol
    JOURNAL OF THE KOREAN MEDICAL ASSOCIATION, 2022, 65 (01): : 9 - 17
  • [10] PATHOGENIC INSIGHTS INTO THE CARDIORENAL SYNDROME IN HEART FAILURE WITH PRESERVED EJECTION FRACTION
    Oh, Albin
    Valero-Munoz, Maria
    Sam, Flora
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2019, 73 (09) : 825 - 825
12345